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I
n retrospect, the history of selenium biochemistry 
does not differ greatly from the study of a number of 
other trace elements in that it occurred over many 
years, progressing from periods of little general interest 
to widespread concern regarding toxicity problems and 
eventually to recognition of selenium as an essential nutrient 
for many forms of life. My involvement in studies on selenium 
metabolism is a classic example of serendipity. I was studying 
an interesting enzyme from an anaerobic bacterium that 
utilized glycine as substrate (glycine reductase), but the 
amounts of pure protein I could isolate were very limited 
because it seemed to be produced only during the very early 
stages of bacterial cell growth. The rich culture medium 
supported continued luxuriant growth of the bacterium, 
but the level of the desired enzyme in the cells merely 
underwent dilution during the process. Finally, after testing 
many known growth stimulatory supplements to no avail, my 
colleagues and I tried two inorganic nutrients, molybdate 
and selenite. This approach was prompted by the report 
that addition of these inorganic compounds to a medium 
used for anaerobic growth of Escherichia coli supported 
synthesis of the enzyme formate dehydrogenase [1]. Much 
to my delight, addition of selenite to our growth medium 
resulted in greatly increased levels of the glycine reductase 
enzyme, and synthesis of the protein continued throughout 
the entire growth period. Thus, a common belief among 
microbiologists that a so-called rich culture medium high in 
tryptone and yeast extract content was nutritionally adequate 
is incorrect if growth of the organism depends on ability to 
synthesize a selenium-containing enzyme. In our case other 
amino acids in the medium could support growth even when 
the trace of selenium was depleted and synthesis of glycine 
reductase stopped. With this unexpected ﬁ  nding, we had an 
ideal biological system for unraveling details of the role of 
selenium in the anaerobic metabolism of glycine. 
The element selenium was discovered by the 
Swedish chemist Berzelius in 1817, and the few organic 
selenium-containing compounds that were prepared during 
the subsequent 100 years were considered primarily as 
chemical curiosities. Finally, in the 1930s, selenium was 
recognized as the potent toxic substance present in various 
types of plants that, when ingested by grazing animals, 
caused chronic symptoms of poisoning. Determination 
of the selenium contents of several native plants from 
Wyoming and South Dakota revealed that members of 
the genus Astragalus accumulated extremely high levels of 
selenium, as much as several thousand parts per million. 
During periods of drought, when appreciable amounts of 
these selenium accumulator plants were consumed in spite 
of their unpleasant odor, animals exhibited symptoms of 
acute poisoning, such as “blind staggers,” loss of appetite, 
paralysis, and ﬁ  nally death. In the arid regions of the western 
United States, selenium accumulation in soils is much higher 
than in areas that have normal rainfall, and as a result 
even ordinary plants, such as cereal grains, from this area 
contain unusually high levels of selenium. From 1930 to the 
mid-1950s, many investigators attempted to determine the 
chemical form(s) of the selenium present in the toxic plants, 
and animal nutritionists tested the effects of various inorganic 
and a few organic selenium compounds administered to 
animals. However, beyond the observation that much of 
the selenium in plant materials was protein-bound, actual 
identiﬁ  cation of the toxic selenium compounds present was 
not accomplished [2]. In retrospect, this is not surprising 
because, as my coworkers and I learned ﬁ  rsthand much later, 
selenium-containing amino acids in proteins are notoriously 
unstable, especially when exposed to oxygen during isolation 
procedures. It took many years for scientists to learn how to 
identify and determine quantitatively the organic selenium 
compounds normally present in biological materials, and 
prior to the mid-1950s, these compounds, especially in 
selenium accumulator plants, were known only for their 
acute toxic effects. As is the case with other elements known 
originally only as toxins and later shown to be required by 
particular living organisms, selenium eventually was found 
to be an essential nutrient for animals and several species of 
bacteria. 
In 1957, Klaus Schwarz, a German scientist working at 
the US National Institutes of Health in Bethesda, Maryland, 
reported that selenium was the essential component of a 
dietary preparation termed Factor 3 that prevented severe 
liver necrosis in rats [3]. Factor 3 preparations isolated from 
brewer’s yeast and from casein were especially effective 
sources of the active selenium component. During this 
same period, an important disease in young chickens and 
turkeys known as exudative diathesis was recognized by 
Nesheim and Scott [4] as a symptom of selenium deﬁ  ciency. 
Administration of Factor 3 or inorganic forms of selenium 
prevented development of the deﬁ  ciency syndrome. However, 
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the basic defect responsible for the selenium deﬁ  ciency 
symptoms remained undeﬁ  ned for several more years. 
Finally, in 1973, it was reported that the catalytic activities 
of two different enzymes depended on the presence of 
selenium in these proteins. One of these enzymes was my 
favorite glycine reductase from anaerobic bacteria [5], and 
the other was mammalian glutathione peroxidase, studied by 
investigators at the University of Wisconsin [6]. It was shown 
that when radioactive selenium (75Se) was provided, it was 
incorporated into both proteins during in vivo synthesis. After 
much effort spent in learning how to handle oxygen-sensitive 
selenium compounds, we ﬁ  nally could identify the selenium 
compound in our glycine reductase protein as selenocysteine, 
an analog of the sulfur-containing amino acid cysteine [7]. 
The selenocysteine occurs at a speciﬁ  c position in the protein 
polypeptide chain. Employing our methods for selenocysteine 
identiﬁ  cation, Tappel and coworkers [8] at the University 
of California at Davis showed that the essential selenium in 
glutathione peroxide was also present as a selenocysteine 
residue in the protein. 
Eventually scientists began to understand how proteins 
are built in living organisms and how the exact location of 
a naturally occurring amino acid in a protein is determined 
by the genetic code, but the inclusion of unusual amino 
acids remained a matter of speculation. Largely through the 
efforts of a young German scientist named August Böck and 
his students at the University of Munich, the question of how 
an amino acid such as selenocysteine could be inserted in a 
highly speciﬁ  c location in a protein could be answered. The 
ﬁ  rst report in 1986 was followed by an impressive series of 
investigations dealing with the biosynthesis of selenoproteins 
in E. coli (reviewed in [9]). As it turned out, a sequence in 
the nucleic acid message that normally told the protein-
synthesizing machinery to terminate the process—the stop 
codon UGA—now triggered a different set of instructions, 
namely, to direct selenocysteine insertion at the UGA 
codon. To achieve this reprogramming, cells have acquired 
an impressive number of additional chemical steps. A new 
amino acid transfer nucleic acid (tRNA) that could read the 
UGA codon was discovered. Selenocysteine derived from a 
serine initially bound to this tRNA is inserted into a growing 
protein chain. In E. coli, the selenium donor required for 
conversion of the serine on the tRNA to selenocysteine 
proved to be selenophosphate, an energy-rich compound in 
which selenium is bonded directly to the phosphorus atom 
[10]. This oxygen-labile selenium compound is known to 
be produced by a number of mammals and bacteria that 
synthesize speciﬁ  c selenoenzymes, and, based on present 
knowledge, a biological role for this reactive selenium 
compound as a “universal selenium donor” may be correct.
A new paper in this issue of PLoS Biology addresses 
the question of why selenium substitution for sulfur at 
the active site of an enzyme can be an advantage and in 
many cases has been preserved in nature [11]. Kim and 
Gladyshev address the catalytic mechanism of mammalian 
methionine-R-sulfoxide reductase (MsrB) 1, which contains 
selenocysteine at the active site, and compare it to the 
catalytic mechanism of the two other forms of the mammalian 
enzyme (MsrB2 and MsrB3) in which cysteine is found 
instead. Reduction of the methionine sulfoxide substrate to 
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Figure 1. Schematic Illustrations Comparing the Enzymatic Reactions of Three Mammalian MsrBs
MsrB1 is a selenium-containing protein, whereas MsrB2 and MsrB3 contain cysteine in the active site.
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methionine by the active site cysteine residue in MsrB2 or 
MsrB3 converts the cysteine thiol to a sulfenic acid derivative 
(SOH), which can be reduced by thioredoxin to regenerate 
cysteine. In contrast, reduction of the sulfoxide substrate 
by MsrB1 converts the ionized selenocysteine residue to 
a selenenic acid derivative (SeOH), which is not reduced 
directly by thioredoxin (Figure 1). However, regeneration 
of MsrB1 by thioredoxin can occur after the SeOH group is 
converted to a selenosulﬁ  de intermediate by reaction with a 
unique cysteine residue in MsrB1.
An impressive number of mutant forms of the genes 
corresponding to the three MsrB enzymes were constructed, 
cloned, and expressed in E. coli, and the catalytic activities 
and substrate afﬁ  nities of the puriﬁ  ed gene products were 
determined in detail by the authors. The native MsrB2 and 
MsrB3 enzymes contain three highly conserved amino acid 
residues—namely, His-77, Val- or Ile-81, and Asn-97—that are 
part of the active sites of these enzymes. Completely different 
amino acid residues, Gly-77, Glu-81, and Phe-97, are found at 
these positions in the fully active form of MsrB1. A series of 
mutant constructs in which the amino acids at positions 77, 
81, and 97 were switched individually or in groups between 
native  selenocysteine and cysteine forms of MsrB, and also 
between selenocysteine- or cysteine-substituted enzymes, were 
analyzed in detail. Several of these mutants exhibited marked 
changes in the ability to utilize the normal electron donor, 
thioredoxin, for enzyme regeneration. Replacement of the 
active site selenocysteine in MsrB1 with cysteine resulted in 
greatly decreased catalytic activity, which could be partially 
restored by introduction of His-77 and Asn-97 at the active 
site. Mutants that were modiﬁ  ed extensively to allow insertion 
of selenocysteine at the active site in place of cysteine were 
also generated, and their characteristics were determined. 
In general, the replacement of cysteine with selenocysteine 
frequently resulted in increased activity with dithiothreitol 
as reductant, but regeneration of active enzyme in these 
constructs by the natural electron donor, thioredoxin, was 
not possible.  Based on the reported ﬁ  ndings, it is clear 
that different critical amino acids in the active sites of the 
selenocysteine and cysteine enzymes are required for their 
maximal catalytic activities, and these also determine electron 
donor speciﬁ  city for enzyme turnover.
The last few years have seen the emergence of numerous 
important physiological roles for the trace element selenium. 
In contrast, it took many years from Berzelius’s discovery of 
this new element in 1817, which he named after Selene, the 
goddess of the moon in ancient Greece, until it attracted 
growing interest, whereupon it gained a bad reputation as a 
toxic substance. Even after its recognition as a required nutrient 
for mammals, the role of selenium as an essential component 
of important antioxidant enzymes synthesized in our cells is not 
widely appreciated. Further studies of the unique properties 
of selenium will help us to understand the selective advantage 
imparted to cells by their investment in selenoprotein 
biosynthesis and its retention during evolution.  
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